Loading clinical trials...
Loading clinical trials...
Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis
Conditions
Interventions
1% Tolnaftate Stick Formula A
1% Tolnaftate Stick Formula B
+1 more
Locations
2
United States
Kuchnir Dermatology and Dermatological Surgery
Framingham, Massachusetts, United States
Kuchnir Dermatology and Dermatological Surgery
Milford, Massachusetts, United States
Start Date
December 30, 2024
Primary Completion Date
February 1, 2026
Completion Date
February 1, 2026
Last Updated
November 28, 2025
NCT00233493
NCT03129321
NCT03897257
NCT01891305
NCT03135912
NCT02606383
Lead Sponsor
Propedix, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions